Clinical, Biochemical and Molecular Characterisation of Newborns With Fatty Acid β‐Oxidation Disorders: Novel Variants in the ACADM , ACADVL and SLC22A5 Genes
Clinical Genetics · 2025
DOI: 10.1111/cge.70083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Irene Hidalgo Mayoral und 7 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Disease Laboratory, Genetics Department, Hospital Universitario La Paz, Madrid, Spain. Hauptthemen laut MEDLINE: Solute Carrier Family 22 Member 5, Acyl-CoA Dehydrogenase, Long-Chain, Acyl-CoA Dehydrogenase, Lipid Metabolism, Inborn Errors. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
In this study, we aimed to assess clinical, laboratory and molecular features of newborns with clinical suspicion for systemic primary carnitine deficiency (CUD), medium‐chain acyl‐CoA dehydrogenase deficiency (MCADD) and very long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD). The implementation of newborn screening programs for fatty acid β‐oxidation disorders (FAODs) has changed the natural course of these diseases, facilitating the initiation of preventive or therapeutic measures for affected newborns shortly after birth. This study included 94 newborns who were admitted between 2016 and 2023 because of biochemical signs of CUD, MCADD and VLCADD, and provided clinical, biochemical and genotypic data. Definitive molecular diagnosis confirmed that 16/94 newborns (17%) were true positives of the NBS, and 17 novel variants were detected in SLC22A5 , ACADM and ACADVL genes. We assessed the clinical evolution of patients over time. This study expands the genotypic spectrum of SLC22A5 , ACADM and ACADVL and highlights the role of genetics in identifying and correctly characterising FAODs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolic Disease Laboratory, Genetics Department, Hospital Universitario La Paz, Madrid, Spain.
- Dyslipemias of Genetic Origin and Metabolic Diseases Group, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain.
- Next-Generation Sequencing Section, Genetic Department, Hospital Universitario La Paz, Madrid, Spain.
- Nutrition and Metabolic Diseases Department, Hospital Universitario La Paz, Madrid, Spain.
ORCID-Profile: Irene Hidalgo Mayoral, Sonia Rodríguez-Nóvoa
Zitieren
APA
Hidalgo Mayoral, I., Herranz Cecilia, A., Rodríguez-Jiménez, C., Carazo Álvarez, A., Bergua Martínez, A., Andrade Guerrero, J. D., Moráis López, A., & Rodríguez-Nóvoa, S. (2025). Clinical, Biochemical and Molecular Characterisation of Newborns With Fatty Acid β‐Oxidation Disorders: Novel Variants in the ACADM , ACADVL and SLC22A5 Genes. Clinical Genetics. https://doi.org/10.1111/cge.70083
Vancouver
Hidalgo Mayoral I, Herranz Cecilia A, Rodríguez-Jiménez C, Carazo Álvarez A, Bergua Martínez A, Andrade Guerrero JD, et al. Clinical, Biochemical and Molecular Characterisation of Newborns With Fatty Acid β‐Oxidation Disorders: Novel Variants in the ACADM , ACADVL and SLC22A5 Genes. Clinical Genetics. 2025. doi:10.1111/cge.70083
BibTeX
@article{HidalgoMayoral2025,
author = {Hidalgo Mayoral, Irene and Herranz Cecilia, Amanda and Rodríguez-Jiménez, Carmen and Carazo Álvarez, Ana and Bergua Martínez, Ana and Andrade Guerrero, José David and Moráis López, Ana and Rodríguez-Nóvoa, Sonia},
title = {Clinical, Biochemical and Molecular Characterisation of Newborns With Fatty Acid β‐Oxidation Disorders: Novel Variants in the ACADM , ACADVL and SLC22A5 Genes},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.70083}
}
EUVIMED